Astria Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $83,030,000.
Profit Margin
| 2014 | 0 | -21.88M | |
|---|---|---|---|
| 2015 | 0 | -32.63M | |
| 2016 | 0 | -36.06M | |
| 2017 | 500K | -27.36M | -5472.8% |
| 2018 | 0 | -25.87M | |
| 2019 | 0 | -26.24M | |
| 2020 | 0 | -37.06M | |
| 2021 | 0 | -30.17M | |
| 2022 | 0 | -50.16M | |
| 2023 | 0 | -72.89M |
ATXS Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 500K | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 26K | 0 | 0 | 0 | 202K | 0 |
Gross profit | 0 | 0 | 0 | 0 | -26K | 0 | 500K | 0 | -202K | 0 |
Operating exp. | ||||||||||
Research and development | 57.32M | 34.26M | 15.55M | 25.59M | 18.31M | 17.04M | 18.68M | 25.45M | 23.03M | 15.68M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 83.03M | 53.50M | 30.35M | 37.43M | 27.08M | 26.37M | 27.59M | 35.55M | 31.65M | 21.68M |
Operating income | -83.03M | -53.50M | -194.97M | -37.43M | -27.08M | -26.37M | -27.09M | -35.55M | -31.65M | -21.68M |
Other income (expenses), net | 10.13M | 1.66M | 64K | 135K | 795K | 176K | -270K | 93K | -971K | -203K |
Income before tax | -72.89M | -51.83M | -194.91M | -37.3M | -26.29M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M |
Income tax expense | 0 | -1.66M | -164.73M | -236K | -50K | 601K | 494K | 930K | 783K | 209K |
Net income | -72.89M | -50.16M | -30.17M | -37.06M | -26.24M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M |
Earnings per share | ||||||||||
Basic EPS | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 |
Diluted EPS | -2.42 | -3.43 | -3.38 | -12.12 | -14.06 | -30.71 | -75.73 | -133.31 | -243.45 | -151.53 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |